FDA Investigates Fungal Infection Associated with Tennessee Compounding Pharmacy

The U.S. Food and Drug Administration, Centers for Disease Control and Prevention and Tennessee Board of Pharmacy are investigating seven adverse events reported from steroid injections compounded by Main Street Family Pharmacy in Newbern, Tenn.

Advertisement

All reported patients received 80 mg injections of preservative-free methylprednisolone acetate, and at least one injection appears to be fungal.

The FDA recommends all healthcare providers refrain from administering any Main Street sterile products and quarantining them until further notice.

More Articles on Anesthesia:
MEDNAX Acquires Anesthesia Specialists of Houston
Survey: 53% Anesthesiologists Struggle With Pulse Oximetry Sensor Readings
ASA Supports Congress in Expanding Anesthesiologists’ HIT Exemptions

Advertisement

Next Up in Anesthesia

  • Anesthesia partnerships are accelerating as hospitals and ASCs look to stabilize coverage, expand surgical capacity and strengthen care team models…

  • Symmetry Anesthesia, a Dallas-based, physician-led anesthesia services provider, named Aaron Stewart as CFO and Jennifer Grover as COO.  Mr. Stewart…

Advertisement

Comments are closed.